Sakar Healthcare Ltd.

•

sakarhealthcare.comBSE: -NSE: SAKAR

Market Cap₹ 2,256 Cr.

Current Price

High / Low₹ 1,024 / 321

Stock P/E62.5

Book Value₹ 150

Price to Book1.64

Dividend Yield0.00 %

ROCE8.4 %

ROE6.5 %

Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Latest quarter profit grew 120.2% YoY, showing strong momentum
Company has consistently been profitable over the last 5 years
Company has delivered good sales growth of 16.4% CAGR over last 5 years
Strong cash generation - operating cash flow backs reported profits (CFO/PAT 2.19x)
Operating margins have improved to 28.0% from 24.6%

CONS

Receivables are growing faster than sales - a possible quality concern
Company has a low return on capital employed of 8.3%
Company has a low return on equity of 6.8% over last 3 years
Equity base is being diluted - shares outstanding up 28.2%
Though reporting repeated profits, the company pays out little dividend (0.0%)
Inventory has been piling up - inventory days up from 51 to 73

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1899.00	37.67	455633.71	0.84	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9100.00	82.59	241576.41	0.33	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4850.00	84.58	184478.41	0.78	566.00	3.28	4921.00	57.32	19.27	33.81
4.	CIPLA	1385.00	33.19	111888.39	0.94	785.55	-39.18	7119.28	4.13	16.00	16.73
5.	ZYDUSLIFE	1121.00	24.78	111820.18	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
6.	LAURUSLABS	1840.00	90.93	99417.45	0.11	362.07	123.94	2026.31	29.10	18.20	31.50
7.	LUPIN	2111.00	17.46	96528.82	0.85	1416.98	16.01	8276.89	34.28	28.86	29.59
8.	DRREDDY	1154.00	29.89	96322.06	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
9.	MANKIND	2328.55	47.09	96179.61	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
10.	AUROPHARMA	1653.30	25.62	95127.23	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	GLENMARK	2427.00	38.10	68495.93	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	SAKAR	1013.90	62.49	2255.92	0.00	10.29	120.19	72.97	38.36	8.43	29.12

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	39	34	37	43	41	43	43	50	53	58	70	71	73
	30	25	28	32	30	31	32	35	40	46	52	45	60
Operating Profit	9	9	9	11	11	12	12	16	13	11	19	26	13
OPM %	23.16%	27.46%	24.20%	25.48%	26.00%	26.88%	27.08%	31.29%	24.10%	19.72%	26.43%	36.91%	17.86%
	2	1	0	1	0	0	0	0	0	1	1	0	2
Interest	2	2	2	2	1	2	1	4	2	2	2	2	2
Depreciation	5	4	4	5	5	5	5	5	6	6	6	6	7
Profit before Tax	4	4	3	5	5	5	5	6	5	5	11	18	15
Tax %	28.10%	12.53%	31.00%	34.79%	48.72%	6.26%	17.15%	7.69%	13.17%	15.30%	6.39%	38.98%	29.47%
Net Profit	0	0	0	0	2	5	5	6	5	5	10	11	10
	1.46	1.68	0.98	1.46	1.10	2.17	2.08	2.66	2.11	2.03	4.59	4.96	4.62

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	83	95	128	133	153	178	272
	63	72	99	100	115	128	203
Operating Profit	20	23	29	33	38	50	69
OPM %	23.56%	23.87%	22.88%	24.94%	25.03%	27.99%	25.45%
	2	1	2	5	3	1	3
Interest	2	2	3	6	8	9	7
Depreciation	7	8	10	15	18	21	25
Profit before Tax	12	13	19	17	16	22	49
Tax %	21.30%	19.27%	19.82%	24.91%	26.60%	18.70%	26.26%
Net Profit	10	11	15	13	12	18	36
EPS	0.00	6.87	8.73	6.75	5.37	7.97	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: 16%
3 Years:: 11%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: 13%
3 Years:: 5%

STOCK PRICE CAGR

10 Years:: —
5 Years:: 43%
3 Years:: 43%
1 Year:: 197%

RETURN ON EQUITY

10 Years:: —
5 Years:: 9%
3 Years:: 7%
Last Year:: 6%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	15	16	17	19	22	22
	66	83	110	154	236	261
	15	40	90	111	69	75
Trade Payables	5	20	31	26	27	21
	14	19	20	26	35	37
Total Liabilities	115	178	268	336	389	415
	66	69	205	267	314	309
Capital Work in Progress	13	49	1	6	0	17
	0	0	7	3	0	0
	11	16	14	15	28	44
	0	0	0	0	21	31
	25	44	41	44	25	15
Total Assets	115	178	268	336	389	415

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	22	15	36	38	24	34
Cash from Investing	-22	-47	-90	-74	-52	-31
Cash from Financing	3	32	55	41	27	-3
	-0	-0	-0	0	0	-0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
PER SHARE
EPS (₹)	6.43	6.84	8.87	6.70	5.37	7.97
Book Value (₹)	54.35	63.04	74.45	91.04	118.41	128.75
Dividend per Share (₹)	0.00	0.00	0.00	0.00	0.00	0.00
Cash EPS (₹)	11.16	12.00	14.52	14.57	13.66	17.49
PROFITABILITY
Operating Margin %	25.99%	25.11%	24.57%	28.45%	25.03%	27.99%
Net Margin %	11.60%	11.28%	11.84%	9.57%	7.61%	9.86%
ROE %	11.83%	11.88%	13.44%	8.48%	5.42%	6.48%
ROCE %	14.79%	13.16%	12.09%	8.95%	7.42%	8.43%
	8.36%	7.30%	6.81%	4.22%	3.22%	4.35%
EFFICIENCY
Debtor Days	36	40	38	50	51	53
Inventory Days	48	51	43	40	51	73
Payable Days	46	90	123	140	117	108
	38	1	-43	-50	-14	19
FINANCIAL HEALTH
Debt to Equity (x)	0.20x	0.43x	0.73x	0.69x	0.31x	0.31x
Interest Coverage (x)	6.41x	6.30x	7.51x	3.85x	3.09x	3.52x
	1.52x	1.01x	1.07x	1.03x	1.21x	1.40x
GROWTH
Revenue Growth %	0.00%	14.17%	35.35%	4.00%	14.99%	15.80%
Operating Profit Growth %	0.00%	10.29%	32.47%	20.41%	9.56%	22.73%
Net Profit Growth %	0.00%	11.01%	42.10%	-15.95%	-8.53%	49.96%
	0.00%	0.00%	0.00%	0.00%	-19.92%	48.59%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	68.64x	26.55x
P/B (x)	0.00x	0.00x	0.00x	0.00x	3.11x	1.64x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	0.00x	0.00x	0.00x	0.00x	21.17x	10.80x

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	53.15	53.15	53.58	53.58	52.86	52.86	52.86	52.86	52.52
	13.52	13.42	13.57	13.60	13.41	13.31	13.05	12.94	12.13
	10.62	10.62	10.88	10.97	11.25	11.43	11.36	11.32	11.37
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	22.71	22.80	21.96	21.85	22.48	22.41	22.73	22.87	23.98

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-01

General Updates

2026-09-01 - Sakar Healthcare Limited has informed the Exchange about Sakar receives 14 oncology product new approvals in the EU (Europe), UK & Canada with 7 business partners

2026-08-29

Copy of Newspaper Publication

2026-08-29 - Sakar Healthcare Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-27

Shareholders meeting

2026-08-27 - Sakar Healthcare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 22, 2026

2026-08-03

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-03 - Sakar Healthcare Limited has informed the Exchange about Transcript of Con-Call.

2026-08-01

Copy of Newspaper Publication

2026-08-01 - Sakar Healthcare Limited has informed the Exchange about Copy of Newspaper Publication

2026-07-29

Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-29 - Sakar Healthcare Limited has informed the Exchange about Link of Recording

2026-07-28

Investor Presentation

2026-07-28 - Sakar Healthcare Limited has informed the Exchange about Investor Presentation

2026-07-24

Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-24 - Sakar Healthcare Limited has informed the Exchange about Schedule of meet/Conference Call.

2026-07-24

Press Release

2026-07-24 - Sakar Healthcare Limited has informed the Exchange regarding a press release dated July 24, 2026, titled "Consolidated and Standalone Un-audited Financial Results for the quarter ended June 30, 2026".

News

Recent coverage and analyst commentary for SAKAR

Loading news…

🤖

AI Stock Analyst

Sakar Healthcare Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1899.00

37.67

455633.71

0.84

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9100.00

82.59

241576.41

0.33

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4850.00

84.58

184478.41

0.78

566.00

3.28

4921.00

57.32

19.27

33.81

CIPLA

1385.00

33.19

111888.39

0.94

785.55

-39.18

7119.28

4.13

16.00

16.73

ZYDUSLIFE

1121.00

24.78

111820.18

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

LAURUSLABS

1840.00

90.93

99417.45

0.11

362.07

123.94

2026.31

29.10

18.20

31.50

LUPIN

2111.00

17.46

96528.82

0.85

1416.98

16.01

8276.89

34.28

28.86

29.59

DRREDDY

1154.00

29.89

96322.06

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

MANKIND

2328.55

47.09

96179.61

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

AUROPHARMA

1653.30

25.62

95127.23

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

GLENMARK

2427.00

38.10

68495.93

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

SAKAR

1013.90

62.49

2255.92

0.00

10.29

120.19

72.97

38.36

8.43

29.12

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

Operating Profit

OPM %

23.16%

27.46%

24.20%

25.48%

26.00%

26.88%

27.08%

31.29%

24.10%

19.72%

26.43%

36.91%

17.86%

Interest

Depreciation

Profit before Tax

Tax %

28.10%

12.53%

31.00%

34.79%

48.72%

6.26%

17.15%

7.69%

13.17%

15.30%

6.39%

38.98%

29.47%

Net Profit

1.46

1.68

0.98

1.46

1.10

2.17

2.08

2.66

2.11

2.03

4.59

4.96

4.62

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

TTM

128

133

153

178

272

100

115

128

203

Operating Profit

OPM %

23.56%

23.87%

22.88%

24.94%

25.03%

27.99%

25.45%

Interest

Depreciation

Profit before Tax

Tax %

21.30%

19.27%

19.82%

24.91%

26.60%

18.70%

26.26%

Net Profit

EPS

0.00

6.87

8.73

6.75

5.37

7.97

—

Dividend Payout %

0.00%

—

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Equity Capital

110

154

236

261

111

Trade Payables

Total Liabilities

115

178

268

336

389

415

205

267

314

309

Capital Work in Progress

Total Assets

115

178

268

336

389

415

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Cash from Investing

-22

-47

-90

-74

-52

-31

Cash from Financing

-3

-0

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

PER SHARE

EPS (₹)

6.43

6.84

8.87

6.70

5.37

7.97

Book Value (₹)

54.35

63.04

74.45

91.04

118.41

128.75

Dividend per Share (₹)

0.00

Cash EPS (₹)

11.16

12.00

14.52

14.57

13.66

17.49

PROFITABILITY

Operating Margin %

25.99%

25.11%

24.57%

28.45%

25.03%

27.99%

Net Margin %

11.60%

11.28%

11.84%

9.57%

7.61%

9.86%

ROE %

11.83%

11.88%

13.44%

8.48%

5.42%

6.48%

ROCE %

14.79%

13.16%

12.09%

8.95%

7.42%

8.43%

8.36%

7.30%

6.81%

4.22%

3.22%

4.35%

EFFICIENCY

Debtor Days

Inventory Days

Payable Days

123

140

117

108

-43

-50

-14

FINANCIAL HEALTH

Debt to Equity (x)

0.20x

0.43x

0.73x

0.69x

0.31x

Interest Coverage (x)

6.41x

6.30x

7.51x

3.85x

3.09x

3.52x

1.52x

1.01x

1.07x

1.03x

1.21x

1.40x

GROWTH

Revenue Growth %

0.00%

14.17%

35.35%

4.00%

14.99%

15.80%

Operating Profit Growth %

0.00%

10.29%

32.47%

20.41%

9.56%

22.73%

Net Profit Growth %

0.00%

11.01%

42.10%

-15.95%

-8.53%

49.96%

0.00%

-19.92%

48.59%

VALUATION

P/E (x)

0.00x

68.64x

26.55x

P/B (x)

0.00x

3.11x

1.64x

Dividend Yield %

0.00%

0.00x

21.17x

10.80x

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

53.15

53.58

52.86

52.52

13.52

13.42

13.57

13.60

13.41

13.31

13.05

12.94

12.13

10.62

10.88

10.97

11.25

11.43

11.36

11.32

11.37

Government

0.00

22.71

22.80

21.96

21.85

22.48

22.41

22.73

22.87

23.98

Sakar Healthcare Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Sakar Healthcare Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI